MH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
McGraw Hill Inc (MH) is not a strong buy for a beginner, long-term investor at this time. While the company has shown some positive trends in revenue growth and analyst sentiment, the lack of significant trading signals, weak financial performance in the latest quarter, and no recent positive news or catalysts make it less compelling for immediate investment.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 66.574, suggesting no overbought or oversold conditions. Moving averages are converging, which does not indicate a clear trend. Key resistance is at 14.577, with support at 12.971.
Analyst sentiment is generally positive, with multiple firms raising price targets and highlighting strong performance in Higher Education and K-12 segments. The stock also has a 60% chance of gaining 5.73% in the next week based on similar candlestick patterns.
The company's latest financials show a significant drop in net income (-61.84% YoY) and EPS (-60.71% YoY), which raises concerns about profitability. Additionally, there are no recent significant insider or hedge fund trading trends, and no recent news or events to act as a catalyst.
In Q3 2026, revenue grew by 4.24% YoY to $434.16M, but net income dropped significantly to -$20.2M (-61.84% YoY), and EPS fell to -0.11 (-60.71% YoY). Gross margin improved slightly to 66.24%, up 0.59% YoY.
Analysts have mixed views but lean positive. UBS raised the price target to $17, JPMorgan to $22, and Morgan Stanley to $21, all maintaining neutral to overweight ratings. However, Baird and BMO Capital lowered their price targets to $19, citing some weaker-than-expected K-12 performance despite overall strong results.
